Brind.

The FDA added labeling across the PCSK9 class, and Kristen Miller discussed Lerochol's features following its approval.

2 reports, 2 independent Updated Mon 00:00
No new developments lately
Reports
2
Developments
2
Repetition
0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

The FDA added labeling across the PCSK9 class, and Kristen Miller discussed Lerochol's features following its approval.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. EU grants approval for lerodalcibep, a PCSK9 inhibitor, following US FDA approval.1 source
  2. FDA adds labeling across PCSK9 class following drug approvals.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped